Cargando…
A self-amplifying RNA vaccine protects against SARS-CoV-2 (D614G) and Alpha variant of concern (B.1.1.7) in a transmission-challenge hamster model
Vaccines for SARS-CoV-2 have been hugely successful in alleviating hospitalization and deaths caused by the newly emerged coronavirus that is the cause of COVID. However, although the parentally administered vaccines are very effective at reducing severe disease, they do not induce sterilizing immun...
Autores principales: | Frise, Rebecca, Baillon, Laury, Zhou, Jie, Kugathasan, Ruthiran, Peacock, Thomas P., Brown, Jonathan C., Samnuan, Karnyart, McKay, Paul F., Shattock, Robin J., Barclay, Wendy S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971064/ https://www.ncbi.nlm.nih.gov/pubmed/35396165 http://dx.doi.org/10.1016/j.vaccine.2022.03.064 |
Ejemplares similares
-
Omicron breakthrough infections in vaccinated or previously infected hamsters
por: Zhou, Jie, et al.
Publicado: (2023) -
Innate Inhibiting Proteins Enhance Expression and Immunogenicity of Self-Amplifying RNA
por: Blakney, Anna K., et al.
Publicado: (2021) -
Polymer formulated self-amplifying RNA vaccine is partially protective against influenza virus infection in ferrets
por: McKay, P F, et al.
Publicado: (2022) -
Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine candidate induces high neutralizing antibody titers in mice
por: McKay, Paul F., et al.
Publicado: (2020) -
Polymeric and lipid nanoparticles for delivery of self-amplifying RNA vaccines
por: Blakney, Anna K., et al.
Publicado: (2021)